transformation committed progenitor leukaemia stem cell initiated mll-af9
leukaemias cancers possess rare population cells capable limitless self-renewal necessary cancer initiation maintenance- eradication cancer stem cells probably critical part successful anti-cancer therapy may explain conventional cancer therapies often effective reducing tumour burden rarely curative given normal cancer stem cells capable self-renewal extent cancer stem cells resemble normal tissue stem cells critical issue targeted therapies developed however remains unclear whether cancer stem cells must phenotypically similar normal tissue stem cells whether can retain identity committed progenitors show leukaemia stem cells lsc can maintain global identity progenitor arose activating limited stem-cell self-renewal-associated programme isolated lsc leukaemias initiated committed granulocyte macrophage progenitors introduction mll af9 fusion protein encoded t p22 q23 lsc capable transferring leukaemia secondary recipient mice four cells transferred possessed immunophenotype global gene expression profile similar normal granulocyte macrophage progenitors however subset genes highly expressed normal haematopoietic stem cells re-activated lsc lsc can thus generated committed progenitors without widespread reprogramming gene expression leukaemia self-renewal-associated signature activated process findings define progression normal progenitor cancer stem cell suggest targeting self-renewal programme expressed abnormal context may possible
